Investing.com - Eli Lilly (NYSE:LLY) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Eli Lilly announced earnings per share of $1.94 on revenue of $6.77B. Analysts polled by Investing.com anticipated EPS of $1.96 on revenue of $6.64B.
Eli Lilly shares are up 45% from the beginning of the year and are trading at $245.05 , down-from-52-week-high.They are outperforming the S&P 500 which is up 21.58% from the start of the year.
Eli Lilly follows other major Healthcare sector earnings this month
Eli Lilly's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Abbott Labs had beat expectations on Wednesday, October 20, 2021 with third quarter EPS of $1.4 on revenue of $10.93B, compared to forecast for EPS of $0.9449 on revenue of $9.56B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar